Synapse

← John A. Spertus

Papers by John A. Spertus

Page 3 · newest first

  1. Abstract 4143155: Sex-Specific Coronary Plaque Characteristics and Risk of Cardiovascular Events: Insights from the ISCHEMIA TrialCirculation · 2024
  2. Abstract 4147235: Sex Differences in Psychosocial Factors and Angina in Patients with Chronic Coronary DiseaseCirculation · 2024
  3. Abstract 4143258: Sex Differences in Health Status Outcomes: Analysis of the ISCHEMIA Randomized Clinical TrialCirculation · 2024
  4. Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid RegurgitationJAMA Cardiology · 2024
  5. Process Mapping to Support the Implementation of a Regional Strategy to Address the Opioid EpidemicHealthcare · 2024
  6. Outcomes with revascularisation versus conservative management of participants with 3-vessel coronary artery disease in the ISCHEMIA trialEuroIntervention · 2024
  7. Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic CardiomyopathyJournal of the American College of Cardiology · 2024
  8. The Psychometric Performance of the Kansas City Cardiomyopathy Questionnaire-12 in Symptomatic Obstructive Hypertrophic CardiomyopathyJournal of Cardiac Failure · 2024
  9. The Kansas City Cardiomyopathy Questionnaire in Relation to New York Heart Association ClassJournal of Cardiac Failure · 2024
  10. Association of health status and hospitalization risk for peripheral artery disease in the PORTRAIT registryVascular Medicine · 2024
  11. Developing an Individualized Patient Decision Aid for Chronic Coronary Disease Based on the ISCHEMIA Trial: A Mixed-Methods StudyCirculation Cardiovascular Quality and Outcomes · 2024
  12. International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA TrialCirculation Cardiovascular Quality and Outcomes · 2024
  13. Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic CardiomyopathyJournal of the American College of Cardiology · 2024
  14. Expanding revascularization trials to women and underserved minorities and shifting to patient-centered outcomes: RECHARGE trials programCurrent Opinion in Cardiology · 2024
  15. Burden of Heart Failure in Patients With Tricuspid Regurgitation and Effect of Transcatheter Repair on Different Subdimensions of Quality of LifeJournal of the American Heart Association · 2024
  16. Optimal Medical Therapy and Outcomes Among Patients With Chronic Heart Failure With Reduced Ejection FractionJACC Heart Failure · 2024
  17. Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trialEuropean Heart Journal · 2024
  18. Association of Baseline Tricuspid Regurgitation With Health Status and Clinical Outcomes After TAVR and Mitral TEERJACC: Cardiovascular Interventions · 2024
  19. Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA‐HCMJournal of the American Heart Association · 2024
  20. Association of Medication Adherence and Health Status in Heart Failure With Reduced Ejection Fraction: Insights From the CHAMP-HF RegistryCirculation Cardiovascular Quality and Outcomes · 2024
  21. Stakeholder Perspectives on the Meaningful Integration of Clinical Informatics Interventions Using Patient-Reported Outcomes in HealthcareACI Open · 2024
  22. Association of Patient Reported Outcomes With Caregiver Burden in Older Patients With Advanced Heart Failure: Insights From the SUSTAIN-IT StudyCirculation Heart Failure · 2024
  23. Aficamten for Symptomatic Obstructive Hypertrophic CardiomyopathyNew England Journal of Medicine · 2024
  24. OR6-5 | Variation in Likelihood of Undergoing Percutaneous Coronary Intervention for ST Segment Elevation Myocardial Infarction among United States HospitalsJournal of the Society for Cardiovascular Angiography & Interventions · 2024
  25. Generalizable Approach to Quantifying Guideline-Directed Medical TherapyCirculation Heart Failure · 2024
  26. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA TrialCirculation Cardiovascular Interventions · 2024
  27. Effect of PCI on Health Status in Ischemic Left Ventricular DysfunctionJACC Heart Failure · 2024
  28. Clinical Impact of Routine Assessment of Patient-Reported Health Status in Heart Failure ClinicCirculation · 2024
  29. One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trialEuroIntervention · 2024
  30. Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA TrialJournal of the American Heart Association · 2024
  31. Physician Estimates and Patient-Reported Health Status in Atrial FibrillationJAMA Network Open · 2024
  32. Validation of the Kansas City Cardiomyopathy Questionnaire in Patients with Tricuspid Regurgitation: The Tri-QOL Study2024
  33. Novel adaptation of the KCC-questionnaire for cardiomyopathy screening in a racially diverse obstetric populationnpj Women s Health · 2024
  34. Association Between Cardiovascular Event Type and Smoking Cessation Rates Among Outpatients With Atherosclerotic Cardiovascular Disease: Insights From the NCDR PINNACLE RegistryCirculation Cardiovascular Quality and Outcomes · 2024
  35. Association of marital/partner status with hospital readmission among young adults with acute myocardial infarctionPLoS ONE · 2024
  36. Use of Calcium Modification During Percutaneous Coronary Intervention After Introduction of Coronary Intravascular LithotripsyJournal of the Society for Cardiovascular Angiography & Interventions · 2024
  37. Remote Heart Failure Symptoms Assessment After Myocardial Infarction Identifies Patients at Risk for DeathJournal of the American Heart Association · 2024
  38. Association Between Delays in Time to Bystander CPR and Survival for Witnessed Cardiac Arrest in the United StatesCirculation Cardiovascular Quality and Outcomes · 2023
  39. Quality of Life After Percutaneous Coronary Intervention Versus Coronary Artery Bypass GraftingJournal of the American Heart Association · 2023
  40. Effect of Mavacamten in Women Compared With Men With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCMCirculation · 2023
  41. Angina and Non-Obstructive Coronary Artery (ANOCA) Patients with Coronary Vasomotor DisordersLife · 2023
  42. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial EndpointsThe Annals of Thoracic Surgery · 2023
  43. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial EndpointsJournal of the American College of Cardiology · 2023
  44. Diastolic Dysfunction and Health Status Outcomes After Transcatheter Aortic Valve ReplacementStructural Heart · 2023
  45. Knowledge is Power, Can it be Leveraged to Improve Heart Failure Care?European Journal of Heart Failure · 2023
  46. Cardiac Arrest Survival at Emergency Medical Service Agencies in Catchment Areas With Primarily Black and Hispanic PopulationsJAMA Internal Medicine · 2023
  47. Patient knowledge and preferences for peripheral artery disease treatmentVascular Medicine · 2023
  48. Efficacy of a web-based healthcare innovation to advance the quality of life and care of patients with an implantable cardioverter defibrillator (ACQUIRE-ICD): a randomized controlled trialEP Europace · 2023
  49. Impact of Marital Stress on 1‐Year Health Outcomes Among Young Adults With Acute Myocardial InfarctionJournal of the American Heart Association · 2023
  50. Longitudinal Pathways Between Physical Activity, Depression, and Perceived Stress in Peripheral Artery DiseaseCirculation Cardiovascular Quality and Outcomes · 2023